Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resistance to ErythroPoietin Effectiveness Algorithm Trial
NCT00319150Phase 3Terminated
- Sponsor
- Queen's University
- Start
- Oct 2006
- Primary completion
- Feb 2009
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin alfa in anemia of chronic kidney disease (CKD-A), sponsored by Queen's University. Started Oct 2006; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00319150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00319150.